[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [QUIET] · [BUSINESS]

2 clusters · 4 sources · 8 days · First seen · Last updated

Teva Pharmaceuticals US antitrust trial litigation

Overview

Teva Pharmaceuticals USA filed a motion in a U.S. District Court seeking to prevent any mention of its Israeli identity during an upcoming antitrust trial. The company argued that references to its headquarters in Tel Aviv or its status as a major Israeli company could unfairly prejudice jurors due to public controversy surrounding the Gaza war. Teva maintained that its nationality is irrelevant to the allegations of a generic-drug price-fixing and market-allocation conspiracy involving drugs such as baclofen and propranolol.

Following this request, health insurer Humana agreed to refrain from referencing Teva’s Israeli national origin during arguments or questioning in the Philadelphia-based proceeding. While the agreement prevents specific references to the company’s origin, it does not preclude the introduction of documents that may inherently reveal Teva’s nationality. The trial is scheduled to begin on September 15.

Entities

Humana · Humana Inc. · Teva Pharmaceutical Industries · Judge Cynthia M. Rufe · Teva Pharmaceuticals USA

Timeline

  1. 30 days ago

    [BUSINESS] 2 sources
    Humana to omit Teva’s Israeli ties in U.S. drug trial

    Humana will not mention Teva’s Israeli ties during a U.S. drug price-fixing trial to prevent juror prejudice related to the Gaza war.

  2. about 1 month ago

    [BUSINESS] 2 sources
    Teva Pharmaceuticals asks US court to bar Israel references in drug price‑fixing trial

    Teva Pharmaceuticals asked a Pennsylvania federal judge to bar any mention of its Israeli ties in a generic‑drug price‑fixing trial, arguing such references could prejudice jurors amid U.S. backlash over the G​

Sources

kfgo.com · wdez.com · wixx.com · worldisraelnews.com